Cargando…

The 17-Gene Genomic Prostate Score Assay Is Prognostic for Biochemical Failure in Men With Localized Prostate Cancer After Radiation Therapy at a Community Cancer Center

PURPOSE: The objective of this study was to assess the association between the Oncotype DX Genomic Prostate Score (GPS) assay and long-term outcomes in men with localized prostate cancer (PCa) after radiation therapy (RT). We hypothesized that the GPS assay is prognostic for biochemical failure (BCF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Canter, Daniel J., Branch, Caroline, Shelnutt, Jason, Foreman, Aimee J., Lehman, Amy M., Sama, Varun, Edwards, David K., Abran, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Scientific Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157115/ https://www.ncbi.nlm.nih.gov/pubmed/37152483 http://dx.doi.org/10.1016/j.adro.2023.101193

Ejemplares similares

The 17-gene Genomic Prostate Score assay as a predictor of biochemical recurrence in men with intermediate and high-risk prostate cancer
por: Helfand, Brian T., et al.
Publicado: (2022)

Assessment of Patients With Prostate Cancer and Their Understanding of the International Prostate Symptom Score Questionnaire
por: Gewanter, Richard M., et al.
Publicado: (2023)

Prostate Cancer Biochemical Recurrence Rates After Robotic-Assisted Laparoscopic Radical Prostatectomy
por: Ginzburg, Serge, et al.
Publicado: (2012)

Association between a 17-gene genomic prostate score and multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa)
por: Leapman, Michael S., et al.
Publicado: (2017)

Trends in Androgen Deprivation Use in Men With Intermediate-Risk Prostate Cancer Who Underwent Radiation Therapy
por: Agrawal, Vishesh, et al.
Publicado: (2022)

Biochemical Recurrence in Gleason Score 7 Prostate Cancer in Korean Men: Significance of the Primary Gleason Grade
por: Ro, Yun Kwan, et al.
Publicado: (2012)

A Comparison Between the Rates of Radiation Oncologist and Urologist Consultations in Men Diagnosed With Prostate Cancer in Northern Ontario, Canada
por: Santi, Stacey A., et al.
Publicado: (2022)

Clinical evaluation of prostate cancer gene 3 score in diagnosis among Chinese men with prostate cancer and benign prostatic hyperplasia
por: Huang, Jin, et al.
Publicado: (2015)

Urinary quality of life outcomes in men who were treated with image-guided intensity-modulated radiation therapy for prostate cancer
por: Salami, Simpa S., et al.
Publicado: (2016)

Effect of Large Prostate Volume on Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy in Patients With Prostate Cancer
por: Natesan, Divya, et al.
Publicado: (2021)

GPS Assay Association With Long-Term Cancer Outcomes: Twenty-Year Risk of Distant Metastasis and Prostate Cancer–Specific Mortality
por: Brooks, Michael A., et al.
Publicado: (2021)

Interim Prostate-Specific Antigen: Predicting for Biochemical Failure During Salvage Radiation Therapy After Prostatectomy
por: Cardoso, Michael, et al.
Publicado: (2021)

Clinical Outcomes of Combined Prostate- and Metastasis-Directed Radiation Therapy for the Treatment of De Novo Oligometastatic Prostate Cancer
por: Imber, Brandon S., et al.
Publicado: (2020)

The Within-Group Discrimination Ability of the Cancer of the Prostate Risk Assessment Score for Men with Intermediate-Risk Prostate Cancer
por: Kang, Ho Won, et al.
Publicado: (2017)

Disparities in staging prostate magnetic resonance imaging utilization for nonmetastatic prostate cancer patients undergoing definitive radiation therapy
por: Ajayi, Ayobami, et al.
Publicado: (2016)

Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19
por: Zaorsky, Nicholas G., et al.
Publicado: (2020)

Evaluation of Polygenic Risk Scores for Prediction of Prostate Cancer in Korean Men
por: Oh, Jong Jin, et al.
Publicado: (2020)

Prostate Cancer Radiotherapy: Increased Biochemical Control and Late Toxicity in Men With Medication Allergies
por: Turchan, William Tyler, et al.
Publicado: (2020)

COMPARISON OF GRADING ACCURACY OF PROSTATE CANCER IN SAMPLES ACQUIRED BY A TARGETED AND SYSTEMIC PROSTATE BIOPSY
por: Pezelj, Ivan, et al.
Publicado: (2022)

Risk of cardiovascular events in men treated for prostate cancer compared with prostate cancer-free men
por: Moustsen, Ida Rask, et al.
Publicado: (2019)

Prostate-Centric Versus Bony-Centric Registration in the Definitive Treatment of Node-Positive Prostate Cancer with Simultaneous Integrated Boost: A Dosimetric Comparison
por: Wu, Trudy C., et al.
Publicado: (2022)

Factors Affecting Prostate Displacement During Volumetric Modulated Arc Therapy in Prone Position After High-Dose-Rate Brachytherapy for Prostate Cancer
por: Sakurai, Takayuki, et al.
Publicado: (2023)

The Excretion of 17-Kestoteroids in Men of Different Age-Groups, with Special Reference to Prostatic cancer
por: Robinson, A. M.
Publicado: (1948)

Hypofractionated image guided radiation therapy followed by prostate seed implant boost for men with newly diagnosed intermediate and high risk adenocarcinoma of the prostate: Preliminary results of a phase 2 prospective study
por: Gresswell, Steven, et al.
Publicado: (2016)

Prostatic Artery Embolization Is Safe and Effective for Medically Recalcitrant Radiation-Induced Prostatitis
por: Parikh, Nainesh, et al.
Publicado: (2020)

Clinical and biochemical outcomes of men undergoing radical prostatectomy or radiation therapy for localized prostate cancer
por: Schreiber, David, et al.
Publicado: (2015)

Impact of Cosmetic Result on Selection of Surgical Treatment in Patients With Localized Prostate Cancer
por: Rojo, María Alejandra Egui, et al.
Publicado: (2014)

Sociodemographic disparities in the utilization of proton therapy for prostate cancer at an urban academic center
por: Woodhouse, Kristina D., et al.
Publicado: (2017)

Toxicity and Outcomes of Moderately Hypofractionated Radiation for Prostate Cancer With Seminal Vesicle Involvement
por: Acklin-Wehnert, Scarlett, et al.
Publicado: (2023)

The effect of the frequency and duration of prostate specific antigen (PSA) measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer
por: Paller, CJ, et al.
Publicado: (2013)

The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence
por: Xiang, Yu-zhu, et al.
Publicado: (2013)

Prostate cancer polygenic risk score and prediction of lethal prostate cancer
por: Klein, Robert J., et al.
Publicado: (2022)

Assessment of biochemical recurrence of prostate cancer (Review)
por: Lin, Xiaozeng, et al.
Publicado: (2019)

The Long-Term Effect of Intensity Modulated Radiation Therapy for Prostate Cancer on Testosterone Levels
por: Horiguchi, Yutaka, et al.
Publicado: (2021)

Genetic variant located on chromosome 17p12 contributes to prostate cancer onset and biochemical recurrence
por: Pavel, Anca Gabriela, et al.
Publicado: (2022)

PRState: Incorporating genetic ancestry in prostate cancer risk scores for men of African ancestry
por: Pagadala, Meghana S., et al.
Publicado: (2022)

A Phase II Trial of a Combination Herbal Supplement for Men with Biochemically Recurrent Prostate Cancer
por: Dorff, Tanya B., et al.
Publicado: (2014)

Factors influencing prostate cancer patterns of care: An analysis of treatment variation using the SEER database
por: Burt, Lindsay M., et al.
Publicado: (2018)

The Role of Cryosurgery of the Prostate for Nonsurgical Candidates
por: Al Ekish, Shadi, et al.
Publicado: (2013)

Biochemical Recurrence in Prostate Cancer Is Associated with the Composition of Lactobacillus: Microbiome Analysis of Prostatic Tissue
por: Kim, Jae Heon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i0nse340mgusc8c1jifqgsdb13